ERBB2 and cancer: Cancer cells without coloring demonstrated negative expression, and ER, PR and HER2 protein expression levels were assessed as positive if IHC staining was strong (+++), equivocal for IHC (++), and negative for IHC (− and +), in accordance with the American Society of Clinical Oncology/College of American Pathologists guidelines (20).